NEW YORK, Feb 24 (Reuters) - Genentech Inc said on Tuesday that the U.S. Patent and Trademark Office has confirmed its claims of the validity of a key patent that governs the biotechnology company’s method of producing some of its drugs.
NEW YORK, Feb 24 (Reuters) - Genentech Inc said on Tuesday that the U.S. Patent and Trademark Office has confirmed its claims of the validity of a key patent that governs the biotechnology company’s method of producing some of its drugs.
